Concepedia

Jocelyn Voell

JV

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

2000

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Frederick National Laboratory for Cancer Research

Leidos (United States)

National Institutes of Health Clinical Center

Jocelyn Voell is an author at National Institute of Allergy and Infectious Diseases specializing in infectious diseases, immunology, and antiviral therapy.

Publications per year

2000–2024

14

Publications

14

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Jason A. Regules, John H. Beigel, Kristopher Paolino et al. · New England Journal of Medicine · 2015 · 395 citations · Full text

, , +11

The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts

Matthew J. Memoli, Rani Athota, Shelby D. Reed et al. · Clinical Infectious Diseases · 2013 · 279 citations · Full text

, , +17

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

, , +3

Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects

Sarah Robertson, Richard T. Davey, Jocelyn Voell et al. · Current Medical Research and Opinion · 2008 · 119 citations

, , +14

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

Pablo Tebas, Marie‐Carmelle Elie, Ednan K. Bajwa et al. · The Lancet Respiratory Medicine · 2017 · 118 citations · Full text

, , +6

1–5 of 14